These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs' test-positive term neonates.
    Author: Javier MC, Krauss A, Nesin M.
    Journal: Pediatrics; 2003 Dec; 112(6 Pt 1):1333-7. PubMed ID: 14654606.
    Abstract:
    OBJECTIVE: To evaluate clinical usefulness of corrected end-tidal carbon monoxide (ETCOc) measurements in healthy, term, Coombs' test-positive neonates and correlate it to the corrected reticulocyte count (RC). METHODS: ETCOc and RC were determined (at 36 +/- 12 hours of age) in 50 Coombs' test-positive neonates and compared with the ETCOc values of 50 Coombs' test-negative neonates. RESULTS: Fifty percent of Coombs' test-positive infants had RCs <5% (within a normal range for a healthy newborn) and ETCOc = 1.8 +/- 0.34 parts per million (ppm) and likely did not exhibit hemolysis. Among infants with elevated RCs, 72% had RCs between 5% and 8% and ETCOc = 2.77 +/- 0.68 ppm, and 28% had RCs >8% and ETCOc = 4.52 +/- 0.83 ppm. There was an almost linear correlation (r = 0.86) between the RC and the ETCOc among Coombs' test-positive infants. The 50 Coombs' test-negative infants had ETCOc = 1.6 +/- 0.45 ppm. Serial ETCOc measurements were performed in 14 Coombs' test-positive infants: in all but 1 infant ETCOc values declined over time. CONCLUSIONS: There is a good correlation between ETCOc and RC in Coombs' test-positive infants. ETCOc >2.5 ppm predicts a significant elevation of RC in 90% of Coombs' test-positive infants.
    [Abstract] [Full Text] [Related] [New Search]